Clinical Trial Update: Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia [Phase 2]

View source ↗

Summary

This entry notes the completion of a Phase 2 dose-ranging study of alfuzosin for lower urinary tract symptoms related to benign prostatic hyperplasia, sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Alfuzosin (alfuzosin)

Snippet

Sponsor: Sanofi | Conditions: Benign Prostatic Hyperplasia | Phase 2 | Status: COMPLETED